Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
SBI Japan-Israel Innovation Fund and Milestone Participate in Investment Round
TEL AVIV, Israel, Dec. 4, 2017 -- (Healthcare Sales & Marketing Network) -- ChemomAb, the bio-pharmaceutical start-up, has completed a $10 million fund raising round led by ... Biopharmaceuticals, Venture Capital ChemomAb, monoclonal antibodies
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Funding | Israel Health | Japan Health | Marketing | Middle East Health | Pharmaceuticals | Venture Capital